Tolcapone |
3.7 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
2-Deoxy-D-glucose |
|
|
|
|
|
|
Positive |
|
249 |
Entacapone |
100 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Lonidamine |
|
|
|
|
|
|
Positive |
|
249 |
3-Bromopyruvate |
|
|
|
|
|
|
Positive |
|
249 |
Imatinib |
|
|
|
|
|
|
Positive |
|
249 |
Oxythiamine |
|
|
|
|
|
|
Positive |
|
249 |
Nilutamide |
79 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Flutamide |
> 100 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Chlorpromazine |
> 300 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Diflunisal |
30 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Benoxaprofen |
> 100 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Troglitazone |
> 100 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Ciglitazone |
> 100 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Troglitazone |
10 μM |
2 minutes |
feline |
cardiomyocytes |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Ciglitazone |
10 μM |
2 minutes |
feline |
cardiomyocytes |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Rosiglitazone |
> 100 μM |
2 minutes |
feline |
cardiomyocytes |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Trimetazidine |
|
|
|
|
|
increase |
Positive |
|
17 |
ranolazine |
|
|
|
|
|
increase |
Positive |
|
17 |
Pioglitazone |
|
|
|
|
|
|
Positive |
|
21 |
2,4-dinitrophenol |
|
|
|
|
|
increase |
Positive |
|
24 |
2-Deoxy-D-glucose |
|
|
human |
SkBr3 breast cancer cells |
MTT assay |
decrease |
Positive |
|
25 |
buformin |
25 μM |
24 hours |
human |
HepG2 cells |
Measurement of ECAR |
increase |
Positive |
p < 0.001 |
15 |
Phenformin |
25 μM |
24 hours |
human |
HepG2 cells |
Measurement of ECAR |
increase |
Positive |
p < 0.001 |
15 |
Oligomycin |
1.1±0.23 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Metformin |
5 mM |
24 hours |
mouse |
NMuMG |
Meassurement of glucose concentration |
increase |
Positive |
p < 0.05 |
172 |
Clotrimazole |
|
|
|
|
|
decrease |
Positive |
|
35 |
Metformin |
5 mM |
24 hours |
mouse |
NT2196 |
Meassurement of glucose concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
24 hours |
human |
MCF10A |
Meassurement of glucose concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
24 hours |
human |
MCF7 |
Meassurement of glucose concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
24 hours |
mouse |
NT2196 |
Meassurement of lactate concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
24 hours |
human |
MCF10A |
Meassurement of lactate concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
48 hours |
mouse |
NMuMG |
Meassurement of glucose concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
48 hours |
mouse |
NT2196 |
Meassurement of glucose concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
48 hours |
human |
MCF10A |
Meassurement of glucose concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
48 hours |
human |
MCF7 |
Meassurement of glucose concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
24 hours |
human |
MCF7 |
Meassurement of lactate concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
48 hours |
mouse |
NMuMG |
Meassurement of lactate concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
48 hours |
mouse |
NT2196 |
Meassurement of lactate concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
48 hours |
human |
MCF10A |
Meassurement of lactate concentration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
48 hours |
human |
MCF7 |
Meassurement of lactate concentration |
increase |
Positive |
p < 0.05 |
172 |
Rotenone |
371±58 nM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
Antimycin A |
100±20 nM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
iodoacetate |
|
|
|
|
|
inhibition |
Positive |
|
278 |
Dichloroacetate |
|
|
|
|
|
inhibition |
Positive |
|
278 |
FCCP |
141±20 nM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
increase |
Positive |
EC50 |
7 |
2-Deoxy-D-glucose |
150 mM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
decrease |
Positive |
EC50 |
7 |
2-Deoxy-D-glucose |
|
|
|
|
|
decrease |
Positive |
|
35 |